Benitez J - Search Results

1

N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.

Agúndez JA, Ladero JM, Olivera M, Lozano L, Fernández-Arquero M, de laConcha EG, Díaz-Rubio M, Benitez J. Agúndez JA, et al. Among authors: benitez j. Scand J Gastroenterol. 2002 Jan;37(1):99-103. doi: 10.1080/003655202753387437. Scand J Gastroenterol. 2002. PMID: 11858170

2

Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.

Agúndez JA, Ladero JM, Olivera M, Abildúa R, Román JM, Benítez J. Agúndez JA, et al. Among authors: benitez j. Oncology. 1995 Jan-Feb;52(1):7-11. doi: 10.1159/000227419. Oncology. 1995. PMID: 7800347

3

CYP2D6 genes and risk of liver cancer.

Agúndez JA, Ledesma MC, Benítez J, Ladero JM, Rodríguez-Lescure A, Díaz-Rubio E, Díaz-Rubio M. Agúndez JA, et al. Among authors: benitez j. Lancet. 1995 Apr 1;345(8953):830-1. doi: 10.1016/s0140-6736(95)92965-7. Lancet. 1995. PMID: 7898230

4

Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.

Agúndez JA, Martínez C, Olivera M, Ledesma MC, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: benitez j. Clin Pharmacol Ther. 1994 Aug;56(2):202-9. doi: 10.1038/clpt.1994.124. Clin Pharmacol Ther. 1994. PMID: 8062497

5

Lung cancer and mutations at the polymorphic NAT2 gene locus.

Martínez C, Agúndez JA, Olivera M, Martín R, Ladero JM, Benítez J. Martínez C, et al. Among authors: benitez j. Pharmacogenetics. 1995 Aug;5(4):207-14. Pharmacogenetics. 1995. PMID: 8528267

6

Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population.

Agúndez JA, Olivera M, Martínez C, Ladero JM, Benítez J. Agúndez JA, et al. Among authors: benitez j. Pharmacogenetics. 1996 Oct;6(5):423-8. Pharmacogenetics. 1996. PMID: 8946474

7

Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.

Agúndez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA, Benítez J. Agúndez JA, et al. Among authors: benitez j. Pharmacogenetics. 1996 Dec;6(6):501-12. doi: 10.1097/00008571-199612000-00003. Pharmacogenetics. 1996. PMID: 9014199

8

Rsa I polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease.

Agúndez J, Ladero J, Díaz-Rubio M, Benítez J. Agúndez J, et al. Among authors: benitez j. Liver. 1996 Dec;16(6):380-3. doi: 10.1111/j.1600-0676.1996.tb00766.x. Liver. 1996. PMID: 9021717

9

CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians.

Agúndez JA, Rodríguez I, Olivera M, Ladero JM, García MA, Ribera JM, Benítez J. Agúndez JA, et al. Among authors: benitez j. Age Ageing. 1997 Mar;26(2):147-51. doi: 10.1093/ageing/26.2.147. Age Ageing. 1997. PMID: 9177672

10

Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: analyses of mutations on NAT2 and C gamma P2E1 genes in a mixed Hispanic population.

Martínez C, Agúndez JA, Olivera M, Llerena A, Ramirez R, Hernández M, Benítez J. Martínez C, et al. Among authors: benitez j. Clin Pharmacol Ther. 1998 Jun;63(6):623-8. doi: 10.1016/S0009-9236(98)90085-6. Clin Pharmacol Ther. 1998. PMID: 9663176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,642 results

Search Page